Harraton Surgery

On this page

• Overview
• Assessing needs
• Delivering evidence-based care and treatment
• How staff, teams and services work together
• Supporting people to live healthier lives
• Monitoring and improving outcomes
• Consent to care and treatment

We looked for evidence that staff involved people in decisions about their care and treatment and provided them advice and support. Staff regularly reviewed people’s care and worked with other services to achieve this.

At our last assessment, we rated this key question as requires improvement. At this assessment, the rating has changed to good.

This service scored 75 (out of 100) for this area. Find out what we look at when we assess this area and How we calculate these scores.

The service made sure people’s care and treatment was effective by assessing and reviewing their health, care, wellbeing and communication needs with them.

Feedback from people using the service was positive. People felt involved in their care, with 94% of respondents in the 2024 GP Patient Survey said they were involved in decisions as much as they wanted to be, compared to the national average of 91%.

Reception staff demonstrated awareness of individual needs by using digital flags to highlight requirements such as longer appointments or interpreter support. Health reviews included checks on wellbeing, with referrals to the social prescriber for patients experiencing issues like isolation or housing concerns.

Carers were identified and coded on the clinical system, with referrals offered to the local Carers Centre. A coding revalidation process was underway at the time of the assessment, which included a wellbeing questionnaire to ensure carers received appropriate, up-to-date support.

The practice generally delivered care and treatment in line with current legislation and evidence-based guidance; however, deficiencies in clinical coding and documentation impacted the accuracy and completeness of clinical records.

Systems were in place to ensure staff were kept up to date with national clinical guidance and best practice through internal systems, protected learning time and regular team meetings.

As part of ongoing quality improvement, the practice carried out two clinical audits. One focused on patients with atrial fibrillation (AF), aiming to reduce stroke risk by ensuring appropriate use of anticoagulant medication. In August 2024, 77% of eligible patients were receiving treatment, and 22% had no clear reason documented for non-treatment. By March 2025, this had improved to 94% receiving the correct medication, and undocumented cases dropped from 20 to 4.

A second audit reviewed long-term prescribing of proton pump inhibitors (PPIs), used to treat stomach acid conditions. Initially, 78% of patients were on high doses with limited review. Following targeted medication reviews, by April 2025, 60% had been safely stepped down to a lower maintenance dose.

A targeted audit was also carried out to review the quality of documentation and prescribing by both a locum and a salaried GP. This was used to provide developmental feedback, improve clinical oversight, and support adherence to evidence-based guidelines.

The service worked well across teams and services to support people. They made sure people only needed to tell their story once by sharing their assessment of needs when people moved between services.

Staff had access to the information they needed to appropriately assess, plan, and deliver people’s care, treatment, and support. The practice worked with other services to ensure continuity of care.

Regular multidisciplinary team (MDT) meetings were held with healthcare professionals and voluntary sector organisations, such as the Carers Centre and Age UK. These meetings supported patients with frailty, complex needs, or those at risk of poor outcomes. The practice also reported working closely with local services to support unpaid carers and people experiencing social isolation, helping to provide holistic, person-centred care that addressed both health and social needs.

The service supported people to manage their health and wellbeing to maximise their independence, choice and control. The service supported people to live healthier lives and where possible, reduce their future needs for care and support.

Staff focused on identifying patients at increased risk, including those in the last 12 months of life, those at risk of developing long-term conditions, and individuals with caring responsibilities. The practice told us they supported national health priorities by referring patients to services such as smoking cessation, weight management programmes, and dietitian clinics.

Leaders also shared that they were participating in a new local initiative, led by the local Integrated Care Board (ICB), which offered obesity treatment using a newer medication that helped regulate blood sugar and support weight loss, although access was limited to patients who met strict eligibility criteria.

The service routinely monitored people’s care and treatment to continuously improve it. They aimed to ensure that outcomes were positive, consistent, and aligned with both clinical standards and people’s expectations.

In 2023, verified data from NHS Digital’s Cervical Screening Programme Coverage Statistics showed that 69.3% of eligible patients had received cervical screening, below the national target of 80%. However, more recent Quality and Outcomes Framework (QOF) data from May 2025 showed improvement, with 82% of women aged 50–64 and 86% of those aged 25–49 receiving screening. These figures are unpublished and have not yet been formally verified.

Monitoring by the UK Health Security Agency (1 April 2023 to 31 March 2024) showed the practice was below the 90% target for childhood immunisations. However, the practice’s own unverified QOF data (up to May 2025) showed improved uptake. This included 100% of babies receiving three doses of the DTaP/IPV/Hib/HepB vaccine, which protects against diphtheria, tetanus, whooping cough (pertussis), polio, Haemophilus influenzae type b, and hepatitis B, by 8 months of age. In addition, 100% of eligible children had received at least one dose of the MMR vaccine (for measles, mumps, and rubella) between 12 and 18 months, and both the DTaP/IPV and MMR boosters between ages 1 and 5.

The service told people about their rights around consent and respected these when delivering person-centred care and treatment.

Staff understood and applied legislation relating to consent. Capacity and consent were clearly recorded. Do not attempt cardiopulmonary resuscitation (DNACPR) decisions were appropriate and were made in line with relevant legislation.